Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain ...
Centessa Pharmaceuticals, which trades on the Nasdaq under the ticker CNTA, develops medicines that aim to transform the lives of patients with unmet medical needs. The stock’s decline reflects ...